-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Learn about an alternative treatment for certain B-cell malignancies. This program is sponsored by Lilly USA, LLC.

Sponsor: Eli Lilly and Company
Program: Product Theaters
Hematology Disease Topics & Pathways:
Research, Clinical Research, Diseases, Treatment Considerations, Lymphoid Malignancies, Non-Biological therapies
Saturday, December 7, 2024: 11:30 AM-12:30 PM
Room 4 (San Diego Convention Center)
Speaker:
John Pagel, MD, PhD, Senior Vice President Clinical Development, Global Head, Hematology
Disclosures:
No relevant conflicts of interest to declare.
For in-person participants only
See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>